About
Technology
Issues
FAQ
Links
Official Page
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.